Core Laboratories (CLB) Cash from Financing Activities (2022 - 2026)

Core Laboratories' Cash from Financing Activities history runs 5 years deep, the most recent figure standing at -$457000.0 for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 89.8% year-over-year to -$457000.0 in Q1 2026; TTM through Mar 2026 was -$27.2 million, a 41.26% increase from a year earlier, with the FY2025 full-year figure at -$31.3 million, up 31.99% from the prior year.
• Cash from Financing Activities rose to -$457000.0 in Q1 2026 per CLB's latest filing, from -$7.1 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $6.1 million in Q1 2023 and bottomed at -$19.4 million in Q4 2024.
• The 5-year median for Cash from Financing Activities is -$6.0 million (2023), against an average of -$7.6 million.
• Across the five-year window, Cash from Financing Activities tumbled 32464.29% in 2024 and jumped 89.8% in 2026, its largest moves.
• Year by year, Cash from Financing Activities stood at -$12.6 million in 2022, then tumbled by 46.97% to -$18.5 million in 2023, then slipped by 4.84% to -$19.4 million in 2024, then jumped by 63.24% to -$7.1 million in 2025, then jumped by 93.58% to -$457000.0 in 2026.
• Per Business Quant, the three latest CLB Cash from Financing Activities figures stand at -$457000.0 (Q1 2026), -$7.1 million (Q4 2025), and -$16.5 million (Q3 2025).